WELCURE DRUGS & PHARMACEUTICAL

BSE: 524661 20 Aug 2025

Healthcare

₹ 12.1

Welcure Drugs & Pharmaceuticals ltd specializes in Pharmaceuticals within the Healthcare sector.

WELCURE DRUGS & PHARMACEUTICAL

BSE: 524661 20 Aug 2025

Healthcare

₹ 12.1

Welcure Drugs & Pharmaceuticals ltd specializes in Pharmaceuticals within the Healthcare sector.

Book Value

9.11

Dividend Yield

0.0%

Debt to Equity

1.2

Stock P/E

5.05

Market Cap

140.0 Cr

WELCURE DRUGS & PHARMACEUTICAL - Share Price & Details

Market Cap

₹140.0

High /Low

15.9 / 6.4

Stock P/E

5.05

Book Value

₹9.11

Dividend Yield

0.0

ROCE

2.45

ROE

₹4.18

Face Value

10.0

PEG Ratio

0.01

EVEBITDA

₹7.38

Debt

123

CMP / FCF

-1.89

Debt to equity

₹1.2

NP Ann

2.17

High price all time

25.0

Piotroski score

₹4.0

Graham Number

22.5

No. Eq. Shares

11.2

Net CF

₹0.11

Net profit

27.7

Price to book value

1.36

Interest Coverage

₹NA

Low price all time

0.36

Industry PE

33.8

Reserves

₹-9.93

Free Cash Flow

₹-222

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
Shyama Computronics and Servic	1.48	0.93	0.67	0.00	5.33	35.5
Triochem Products Ltd.,	3.25	-4.52	NA	-18.44	0
WELCURE DRUGS & PHARMACEUTICAL	231.21	25.39	212.11	0.33	140.0	5.05
TYCHE INDUSTRIES LTD.	143.71	10.26	123.65	1.00	139	11.5
Smruthi Organics Limited	381.70	22.30	380.95	1.95	135	39.8

Peer Comparison Chart

About WELCURE DRUGS & PHARMACEUTICAL

Welcure Drugs & Pharmaceuticals ltd, with Security Code 524661, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Welcure Drugs & Pharma board to consider share split, bonus issue this month

(12 Aug 2025)

Welcure Drugs & Pharmaceuticals is set to consider a stock split of 1:10 and a bonus issue of 1:1 in its upcoming board meeting on August 22...

Welcure Drugs & Pharmaceuticals to consider stock split, bonus

(12 Aug 2025)

Welcure Drugs & Pharmaceuticals to discuss stock split and bonus issue in upcoming Board of Directors meeting.

Welcure Drugs & Pharmaceuticals Announces Proposal For Bonus Issue And Stock Split

(12 Aug 2025)

Welcure Drugs & Pharmaceuticals (BSE: 524661) today announced that its Board of Directors will meet on Friday August 22, 2025 to consider...

1:10 Stock split, 1:1 bonus share: 100 shares will become 2000 - meeting on THIS date

(12 Aug 2025)

1:10 Stock split , 1:1 bonus share: Shares of Welcure Drugs & Pharmaceuticals zoomed 5 per cent to hit the upper circuit limit on Monday...

Welcure Drugs to consider proposal for stock split and bonus issue

(11 Aug 2025)

On 22 August 2025. Welcure Drugs & Pharmaceuticals announced that a meeting of its Board of Directors is scheduled for 22 August 2025,...

Shareholder Jackpot? Pharma Stock Proposes 1:10 Split And 1:1 Bonus To Woo Investors; Buy For Twin Treat?

(11 Aug 2025)

Welcure Drugs & Pharmaceuticals Ltd. is a well-known pharmaceutical firm in India that was founded in 1992 and produces and sells a variety...

Quarterly Table

Standalone

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	8.8	21.2
Expenses	0.0	0.1	0.0	0.1	0.1	0.1	0.3	22.7	7.9	20.5
Operating Profit	0.0	-0.1	0.0	-0.1	-0.1	-0.1	-0.3	1.8	0.9	0.7
OPM %	0%	0%	0%	0%	0%	0%	0%	7.51%	10.4%	3.38%
Other Income	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9
Interest	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Depreciation	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Profit before tax	0.0	0.2	0.0	-0.1	0.0	0.0	-0.3	1.8	0.9	2.6
Tax %	0%	0%	0%	0%	0%	0%	0%	0%	-54.6%	0%
Net Profit	0.0	0.2	0.0	-0.1	0.0	0.0	-0.3	1.8	0.4	2.5
EPS in Rs			0	-0.01	0	-0.01	-0.26	0.16	0.04	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	18700%

Stock Price CAGR
10 Years:	25%
5 Years:	83%
3 Years:	26%
1 Year:	90%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	4%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	-124%

Stock Price CAGR
10 Years:	25%
5 Years:	83%
3 Years:	26%
1 Year:	90%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

WELCURE DRUGS & PHARMACEUTICAL

WELCURE DRUGS & PHARMACEUTICAL

WELCURE DRUGS & PHARMACEUTICAL - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About WELCURE DRUGS & PHARMACEUTICAL

Latest News

Welcure Drugs & Pharma board to consider share split, bonus issue this month

Welcure Drugs & Pharmaceuticals to consider stock split, bonus

Welcure Drugs & Pharmaceuticals Announces Proposal For Bonus Issue And Stock Split

1:10 Stock split, 1:1 bonus share: 100 shares will become 2000 - meeting on THIS date

Welcure Drugs to consider proposal for stock split and bonus issue

Shareholder Jackpot? Pharma Stock Proposes 1:10 Split And 1:1 Bonus To Woo Investors; Buy For Twin Treat?

Penny stock hits upper circuit after 1:10 stock split, 1:1 bonus shares move; details here

Multibagger pharma penny stock at Rs 10.59/share: Board is likely to announce 1:1 bonus share & 1:10 stock split

Welcure Drugs to hold board meeting over 1:1 bonus share issue | Tap to know more | Inshorts

Welcure Drugs & Pharmaceuticals Ltd posts robust Q1FY26 performance with Rs 23.29 crore net profit

Welcure Drugs & Pharmaceuticals posts Rs 23.29 crore profit for Apr-Jun quarter

This Multibagger Pharma Stock Hits 5% Upper Circuit- What Fueled Its Q1FY26 Result?

Penny Stock Hits Upper Circuit After Q1 Surge

Welcure Drugs & Pharmaceuticals posts Rs 23.29 cr profit for Apr-Jun quarter

Welcure Drugs & Pharma Shares Locks 5% Upper Circuit On Declaring Q1FY26 Results

Multibagger pharma stock: Shares hit 5% upper circuit after Q1 results; 697% RETURNS in 5 yrs

वेलक्योर ड्रग्स एंड फार्मास्युटिकल्स ने अप्रैल-जून तिमाही में दर्ज किया 23.29 करोड़ रुपये का लाभ

Welcure Drugs & Pharmaceuticals Reports Strong Financial Growth in June 2025 Results

Welcure Drugs & Pharmaceuticals reports standalone net profit of Rs 23.30 crore in the June 2025 quarter

Pharmaceuticals Limited (524661) Maintain Its Valuation - Phenomenal returns

Pharmaceuticals Limited (524661)’s Trend in 2025 - Unprecedented growth rates

Pharmaceuticals Limited (524661)’s Trend in 2025 - Unmatched market performance

Pharmaceuticals Limited (524661)’s Trend in 2025 - Triple-digit profit margins

Welcure Drugs Soars 5% After ₹85.6 Cr Export Orders from Global Clients

Welcure Drugs Faces Significant Selling Pressure Amidst Recent Price Decline

₹145 करोड़ की Welcure Drugs, जून तिमाही में पूरा किया ₹300 करोड़ का विदेशी ऑर्डर

Welcure Drugs & Pharmaceuticals Completes Seven Export-Sourcing Assignments Worth Rs. 299.91 Crore During Q1 FY 2025-26

Welcure Drugs completes export-sourcing orders worth Rs 300 cr in Q1

Welcure Drugs & Pharmaceuticals executes worth ₹300 cr orders

Welcure Drugs And Pharmaceuticals Surges To Upper Circuit On Completing Rs 299.91 Cr Order In Q1FY26

Small-cap stock under ₹20: Pharma stock hits upper circuit after THIS update on ₹300 crore export order

Welcure Drugs & Pharmaceuticals completes orders of ₹299.91 crore | Tap to know more | Inshorts

Multibagger pharma penny stock under Rs 15 hit upper circuit after completing export-sourcing orders aggregating to Rs 299.91 crore

₹12 के शेयर को खरीदने की लूट, लगा अपर सर्किट, कर्ज फ्री है कंपनी!

Welcure Drugs Faces Intense Selling Pressure Amid Significant Price Declines

Why is Welcure Drugs falling/rising?

Welcure Drugs And Pharmaceuticals Share Price Jumps 5% After ₹85.6 Cr Export Orders

Multibagger stock: Money doubled in THIS pharma company's shares in 1 yr; do you own?

Welcure Drugs को मिले 85 करोड़ के ऑर्डर

Welcure Drugs & Pharma secures export orders worth Rs 86 crore

Welcure Drugs & Pharmaceuticals bags ₹86 cr order from Giant Exim

Small-cap stock below ₹20 hits upper circuit after THIS export order update

Welcure Drugs & Pharma shares hit upper circuit on securing export orders

Welcure Drugs & Pharma secures export orders worth Rs 86 cr

Welcure Drugs Secures Rs 86 Cr Export Orders

Welcure Drugs & Pharmaceuticals Sees Strong Buying Activity Amid Market Shift

Welcure Drugs & Pharmaceuticals secures ₹85.6 crore export orders | Tap to know more | Inshorts

Welcure Drugs and Pharmaceuticals Share Price Hits Upper Circuit After ₹85.6 Cr Export Order Surge

Welcure Drugs Secures Rs 85.6 Cr Export Order; Stock Ended In 5% Upper Circuit Limit

Penny stock hits 5% upper circuit after securing export order worth ₹85.6 Cr from Global Clients

Penny Stock Under Rs 15 Locked in the 5 Per Cent Upper Circuit Secures Rs 85.6 Crore Export Orders

Welcure Drugs & Pharmaceuticals signs ₹517 crore supply mandate with Thailand firm

Multibagger stock: 2X return in THIS pharma counter in 1 year; do you own?

16 रुपए से कम कीमत वाले फार्मा सेक्टर के इस पेनी स्टॉक में बड़ी खबर, प्राइस लगातार पांचवें दिन अपर सर्किट तक पहुंचे

5 ವರ್ಷದಲ್ಲಿ 2303% ರಿಟರ್ನ್; ಈಗ ವಿದೇಶದಲ್ಲಿ ಗುತ್ತಿಗೆ ಪಡೆದ ಫಾರ್ಮಾ ಕಂಪನಿ, ಅಪ್ಪರ್ ಸರ್ಕ್ಯೂಟ್ ಹೊಡೆದ ಷೇರು

Stocks To Watch, June 19: Siemens Energy India, Vedanta, Jio Financial Services, Inox India, Welcure Drugs, Vodafone Idea

फार्मा कंपनी को थाईलैंड से मिला करोड़ों का एक्सपोर्ट आर्डर तो इसके शेयर में लगने लगा अपर सर्किट, आपके पास है?

5 साल में 2,303% का रिटर्न, अब 15 रुपये के पेनी स्टॉक में लगा 5% का अपर सर्किट, कंपनी को विदेश में मिला कॉन्ट्रैक्ट

Small-cap stock under ₹20 hits upper circuit despite sell-off in Indian stock market

Welcure Drugs & Pharmaceuticals signs Rs 517 cr supply mandate with Thailand firm

Welcure Drugs & Pharmaceuticals Ltd secures ₹517 Crore Global Sourcing Mandate

Welcure Drugs Signs Rs 517 Cr Supply Deal

Welcure Drugs & Pharma bags ₹517 cr order from Thailand company

₹15 से कम के स्मॉल कैप स्टॉक को खरीदने की मची लूट, इस ऐलान का है असर

Welcure Drugs & Pharmaceuticals signs Rs 517 crore supply mandate with Thailand firm

Healthcare Stock Under Rs 20 Signs Major Rs 517 Cr Overseas Deal, Eyes Rs 25.85 Cr Service Income

Penny stock hits 5% upper circuit after securing ₹517 Cr Pharma Sourcing Deal with Thai Firm

Agarwal Fortune India standalone net profit rises 900.00% in the March 2025 quarter

Welcure Drugs & Pharmaceuticals reports standalone net profit of Rs 2.54 crore in the March 2025 quarter

Inani Securities standalone net profit declines 75.40% in the March 2025 quarter

LS Industries reports standalone net loss of Rs 0.85 crore in the March 2025 quarter